Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Lipigon Pharmaceuticals

0.01 SEK

-5.71 %

Less than 1K followers

LPGO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lipigon Pharmaceuticals

201920202021202220232024
Revenue1.74.02.216.410.3
growth-%130.2 %-44.9 %-37.3 %
EBITDA-4.9-7.8-41.2-37.7-12.4-25.5
EBIT-4.9-7.8-41.2-37.7-12.4-25.6
Profit before taxes-5.0-8.1-41.1-37.7-12.1-25.3
Net income-5.0-8.1-41.1-37.7-12.1-25.3
EPS-0.29-0.47-2.38-1.63-0.15-0.14
Dividend0.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

201920202021202220232024
EBITDA-%-283.2 %-195.1 %-1,862.0 %-75.3 %-248.0 %
EBIT-%-283.2 %-195.1 %-1,863.0 %-75.4 %-248.6 %
ROE-229.9 %-62.1 %-179.0 %-974.4 %-42.6 %-325.5 %
ROI-155.3 %-52.9 %-139.7 %-348.5 %-36.1 %-170.4 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.